Ms. Bitar et al., DIABETES-INDUCED SUPPRESSION OF IGF-1 AND ITS RECEPTOR MESSENGER-RNA LEVELS IN RAT SUPERIOR CERVICAL-GANGLIA, Diabetes research and clinical practice, 38(2), 1997, pp. 73-80
Insulin-like growth factor-I (IGF-I) is implicated in the development:
survival and maintenance of function of sympathetic and sensory neuro
ns. These neurons are affected at an early stage during the course of
diabetes, Reverse transcriptase polymerase chain reaction (RT-PCR) bas
ed assay revealed that rat superior cervical ganglia (SCG) express mRN
A transcripts for IGF-I and its receptor. Moreover, specific membrane
protein binding sites for IGF-I within the SCG have also been demonstr
ated using competition-inhibition and affinity cross-linking technique
s. An induction of diabetes with streptozotocin (STZ, 55 mg/kg, i.v.)
produced a marked decrease in the SCG levels of mRNA transcripts for I
GF-I and its receptor. Concentrations of circulating IGF-I and its rec
eptor protein within the SCG were also reduced in this disease state.
Insulin treatment partially prevented diabetes-related alterations in
circulating IGF-I and the SCG-IGF-I system. Overall, the data describe
d in this study may be of value in understanding the pathogenetic mech
anism(s) responsible for the development of diabetic sympathetic neuro
pathy. (C) 1997 Elsevier Science Ireland Ltd.